NCT06484686View on ClinicalTrials.gov

An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

414

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2031

Conditions
Varicella
Interventions
BIOLOGICAL

Live Attenuated Varicella Vaccine

lyophilized powder, subcutaneous injection

Trial Locations (1)

450016

Henan Provincial Center for Disease Control and Prevention, Zhengzhou

All Listed Sponsors
lead

Sinovac (Dalian) Vaccine Technology Co., Ltd.

INDUSTRY

NCT06484686 - An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine | Biotech Hunter | Biotech Hunter